G+T and Cooley have advised Eucalyptus. Gunderson Dettmer and Osborne Clarke have advised Hims & Hers Health, Inc. K&L Gates has advised Blackbird Ventures. Australian digital...
Hims & Hers to Acquire Eucalyptus in USD1.15 Billion Transaction
Partner Matthew Edwards Joins Boies Schiller Flexner in Washington DC in Family Law Practice
Boies Schiller Flexner LLP announced that Matthew Edwards has joined the firm’s Washington, D.C. office as a partner in the family law practice. Matt’s practice focuses […]
Halma Acquires E2S for £230 Million to Expand Safety Technology Offering
Osborne Clarke has advised Halma plc on its acquisition of E2S advised by Mishcon de Reya. Halma plc has completed the acquisition of UK-based E2S for...
Basecamp Research Ltd’s $20 Million Series A Funding Round
Osborne Clarke advised Basecamp Research Ltd on the deal. Basecamp Research Ltd (“Basecamp”), a company that designs protein products based on the largest knowledge graph of...
Turbine’s €20 Million Financing Round
Osborne Clarke advised Turbine on the deal. Turbine, a company developing a cell behavior simulation platform, has announced the closing of a €20 million Series A...
Epitopea’s US$14 Million Financing to Advance Cancer Immunotherapeutics
Osborne Clarke has advised a transatlantic syndicate of top-tier life sciences investors including Advent Life Sciences, CTI Life Sciences, Cambridge Innovation Capital and Fonds de solidarité...
Redx Pharma plc’s £34.3 Million Placing
Osborne Clarke has advised WG Partners LLP, Panmure Gordon (UK) Limited and Stifel Nicolaus Europe Limited. WG Partners LLP, Panmure Gordon (UK) Limited and Stifel Nicolaus...
Ashfield Huntsworth’s Acquisition of Research Partnership
Osborne Clarke advised the shareholders of The Research Partnership Limited on the deal. The Research Partnership Limited (Research Partnership) on its acquisition by Ashfield Huntsworth for...
Uniphar plc’s Acquisition of Events4Healthcare
Osborne Clarke has advised Uniphar plc on the deal. Uniphar plc acquired UK-based brand commercialisation and pharmaceutical marketing agency, Events4Healthcare. E4H offers a wide range of...
Uniphar plc’s Acquisition of Devonshire Healthcare Services
Osborne Clarke has advised Uniphar plc on the deal. Uniphar plc acquired UK-based pharmaceutical distributor Devonshire Healthcare Services (“Devonshire”). Devonshire has provided access to unlicensed and...
Grifols’ EUR1.1 Billion Acquisition Of Biotest
Osborne Clarke has advised Grifols on the deal. Grifols signed an agreement with the Hong Kong’s Tiancheng International Investment Ltd. to acquire 100% of the shares...
Forefront RF’s £1.5 Million Investment Round
Osborne Clarke has advised Science Create Ventures, Foresight Williams Technology and BGF. The £1.5m investment round included Science Create Ventures, Foresight Williams Technology, BGF and The Cambridge Angels. This...